SEC Filings

Filing date	Form	Description	View
06/08/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-001432.pdf 0001950047-23-001432.rtf
06/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-001648.pdf 0001950047-23-001648.rtf 0001950047-23-001648.xls
07/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-002324.pdf 0001950047-23-002324.rtf 0001950047-23-002324.xls
08/11/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-003012.pdf 0001950047-23-003012.rtf 0001950047-23-003012.xls
09/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-004019.pdf 0001950047-23-004019.rtf 0001950047-23-004019.xls
10/16/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-004506.pdf 0001950047-23-004506.rtf 0001950047-23-004506.xls
11/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-004932.pdf 0001950047-23-004932.rtf 0001950047-23-004932.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008431.pdf 0001179110-14-008431.rtf 0001179110-14-008431.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008432.pdf 0001179110-14-008432.rtf 0001179110-14-008432.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008433.pdf 0001179110-14-008433.rtf 0001179110-14-008433.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.